Content:

Postpartum haemorrhage (PPH) is a leading cause of maternal mortality worldwide. Uterine atony is the main cause of PPH and the use of prophylactic uterotonic agents is an integral component of the active management of the third stage of labour to prevent PPH. Sponsored by Ferring Pharmaceuticals, this 45-minute module features three short lectures that were presented at the RCOG World Congress Meeting 2018. The first lecture highlights updated data from the Cochrane Review on available uterotonics agents with focus on Carbetocin; the second lecture focuses on an anaesthesiologist's perspectives on the clinical implications of the haemodynamic effects of Oxytocin and Carbetocin and the last lecture, focuses on an upcoming clinical trial that will compare 3 uterotonic agents, Carbetocin, Oxytocin and Syntometrine via the intra-muscular route following vaginal birth.

• Lecture

■ Participants must obtain a minimum score of 4/5 (80%) to be awarded 1 point.